Peritoneal Neoplasms Clinical Trials in Montpellier
3 recruitingMontpellier, France
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Ovarian NeoplasmsNeoplasm MetastasisFallopian Tube Neoplasms+1 more
Eli Lilly and Company1,080 enrolled260 locationsNCT07213804
Recruiting
Not Applicable
Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
Postoperative ComplicationsHyperthermic Intraperitoneal ChemotherapyPeritoneal Neoplasms+2 more
Assistance Publique - Hôpitaux de Paris140 enrolled7 locationsNCT06351475
Recruiting
Not Applicable
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
Fallopian Tube NeoplasmsCarcinoma, Ovarian EpithelialPeritoneal Neoplasms
Institut du Cancer de Montpellier - Val d'Aurelle300 enrolled1 locationNCT03976999